Machine Learning Deep Bio’s AI Algorithm Helps Risk Stratification for Prostate Cancer Cision PRWeb May 12, 2023 Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics support software, announced that Dr. Lotan from Johns Hopkins Medicine…
Machine Learning Deep Bio and Visiopharm Announce a Collaborative Integration of a Clinical-Grade AI Prostate Cancer… AIT News Desk Nov 21, 2022 Deep Bio, a leading AI biotech dedicated to cancer diagnosis, and Visiopharm, a world leader in AI-powered image analysis and tissue mining for…
Healthcare Management Deep Bio Acquires MDSAP Certification, Paving the Way for Global Expansion AIT News Desk Aug 17, 2022 Deep Bio, a pioneer in medical AI for pathologic cancer diagnostics, announced that it has been recently granted Medical Device Single Audit Program…
Healthcare Management Deep Bio successfully integrates DeepDx Prostate algorithm into HALO AP platform from Indica Labs AIT News Desk Aug 10, 2022 Deep Bio, a company concentrating on SaMD (Software as a Medical Device) for digital pathology, offering clinically validated, AI-based DeepDx…
Healthcare Management Deep Bio’s AI-based Cancer Diagnostic Software Demonstrated Uropathologist-level Performance AIT News Desk May 20, 2022 Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics software, announced that the research results of an external validation…
Diagnosis Deep Bio’s AI-Based Antibody Optimization Platform Applied to Parkinson’s Disease AIT News Desk Aug 13, 2021 Collaborative research between Deep Bio and AngioLab for the development of a new mAb for PD Deep Bio, a leading AI biotech dedicated to…
Life Sciences Gestalt Diagnostics And Deep Bio Announce Strategic Relationship To Deliver Image Analysis… AIT News Desk Jul 15, 2021 Gestalt Diagnostics and Deep Bio announced their strategic relationship on the development of an integrated workflow for pathologists to use…